UroGen Pharma Ltd. (URGN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1235717,
    "name": "UroGen Pharma Ltd.",
    "stock_name": "UroGen Pharma Ltd.",
    "full_name": "UroGen Pharma Ltd.",
    "name_url": "stocks-analysis/urogen-pharma",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "24.28",
    "chg": -0.1,
    "chgp": "-0.41%",
    "dir": -1,
    "prev_price": "24.38",
    "mcapval": "990.98",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "IL0011407140",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "424.13 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/urogen-pharma-1235717-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "UroGen Pharma Hits New 52-Week High of $23.89, Up 81.99%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/urogen-pharma-hits-new-52-week-high-of-2389-up-8199-3686468",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/UroGenPharma_priceRelatedfactors_3686468.png",
        "date": "2025-11-10 17:18:27",
        "description": "UroGen Pharma achieved a new 52-week high of USD 23.89 on November 7, 2025, marking an 81.99% increase over the past year. With a market capitalization of USD 991 million, the company has a notable return on equity of 165.96%, despite being currently loss-making."
      },
      {
        "title": "UroGen Pharma Hits Day High with 18.83% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/urogen-pharma-hits-day-high-with-1883-surge-in-stock-price-3680263",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/UroGenPharma_priceRelatedfactors_3680263.png",
        "date": "2025-11-07 16:40:42",
        "description": "UroGen Pharma has seen notable stock activity, with significant gains over various time frames, including a 121.03% increase year-to-date. Despite challenges such as a negative book value and slow long-term growth, the company boasts a high return on equity of 165.96%."
      },
      {
        "title": "UroGen Pharma Hits New 52-Week High of $23.64, Up 84.34%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/urogen-pharma-hits-new-52-week-high-of-2364-up-8434-3680186",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/UroGenPharma_priceRelatedfactors_3680186.png",
        "date": "2025-11-07 16:08:47",
        "description": "UroGen Pharma has achieved a new 52-week high of USD 23.64, significantly up from its low of USD 3.42, reflecting an impressive one-year performance. With a market cap of USD 991 million, the company shows strong financial metrics but remains loss-making, indicating evolving market dynamics in the Pharmaceuticals and Biotechnology sector."
      },
      {
        "title": "Is UroGen Pharma Ltd. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-urogen-pharma-ltd-technically-bullish-or-bearish-3673680",
        "imagepath": "",
        "date": "2025-11-05 11:22:37",
        "description": "As of 31 October 2025, the technical trend for UroGen Pharma Ltd. has changed from mildly bullish to bullish. The current stance is bullish, supported by bullish signals from the daily moving averages and Bollinger Bands on both weekly and monthly time frames. However, the MACD shows a mildly bearish signal on the weekly, indicating some caution. \n\nIn terms of performance, UroGen has significantly outperformed the S&P 500 year-to-date with a return of 86.01% compared to the S&P 500's 16.30%. Over the past year, the stock also shows strong performance at 62.38% against the S&P 500's 19.89%...."
      },
      {
        "title": "Is UroGen Pharma Ltd. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-urogen-pharma-ltd-technically-bullish-or-bearish-3670858",
        "imagepath": "",
        "date": "2025-11-04 11:34:07",
        "description": "As of 31 October 2025, the technical trend for UroGen Pharma Ltd. has changed from mildly bullish to bullish. The current stance is bullish, driven by bullish signals from the daily moving averages and Bollinger Bands on both weekly and monthly time frames. However, the MACD indicates a mildly bearish position on the weekly chart, while the monthly remains bullish. The KST shows a similar pattern with a mildly bearish weekly and bullish monthly. Dow Theory reflects a mildly bullish weekly stance but a mildly bearish monthly outlook. \n\nIn terms of performance, UroGen Pharma has significantly outperformed the S&P 500 year-to-date with a return of 93.62% compared to the S&P's 16.30%, and over the past year, it has returned 69.02% against the S&P's 19.89%...."
      },
      {
        "title": "Is UroGen Pharma Ltd. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-urogen-pharma-ltd-technically-bullish-or-bearish-3666462",
        "imagepath": "",
        "date": "2025-11-03 11:33:54",
        "description": "As of 31 October 2025, the technical trend for UroGen Pharma Ltd. has changed from mildly bullish to bullish. The current stance is bullish, driven by bullish signals from the daily moving averages and Bollinger Bands on both weekly and monthly time frames. However, the MACD and KST indicators show a mildly bearish trend on the weekly, which suggests some caution. \n\nIn terms of performance, UroGen has outperformed the S&P 500 significantly over the past week (7.91% vs. 0.71%) and month (14.90% vs. 1.92%), and has also shown strong year-to-date returns (92.21% vs. 16.30%). However, it has underperformed over the 3-year and 5-year periods compared to the S&P 500. Overall, the current bullish trend is supported by strong short-term performance, despite mixed signals from some indicators...."
      },
      {
        "title": "Is UroGen Pharma Ltd. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-urogen-pharma-ltd-technically-bullish-or-bearish-3664578",
        "imagepath": "",
        "date": "2025-11-02 11:18:26",
        "description": "As of 31 October 2025, the technical trend for UroGen Pharma Ltd. has changed from mildly bullish to bullish. The current stance is bullish overall, with key indicators supporting this view including bullish signals from the daily moving averages and both weekly and monthly Bollinger Bands. However, the weekly MACD and KST are mildly bearish, indicating some caution in the short term. The Dow Theory shows a mildly bullish stance on the weekly timeframe but is mildly bearish on the monthly.\n\nIn terms of performance, UroGen Pharma has significantly outperformed the S&P 500 in the year-to-date return (92.21% vs. 16.30%) and over the past year (66.97% vs. 19.89%), though it has underperformed over the 3-year and 5-year periods...."
      },
      {
        "title": "UroGen Pharma Hits Day High with 9.46% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/urogen-pharma-hits-day-high-with-946-surge-in-stock-price-3649335",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/UroGenPharma_priceRelatedfactors_3649335.png",
        "date": "2025-10-27 17:39:59",
        "description": "UroGen Pharma's stock has shown strong performance, gaining 9.46% on October 24, 2025, and achieving a 56.78% return over the past year. Despite challenges such as a negative book value and modest long-term growth, the company's market capitalization is currently USD 991 million."
      },
      {
        "title": "UroGen Pharma Hits Day High with 15.59% Surge, Outperforming S&P 500",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/urogen-pharma-hits-day-high-with-1559-surge-outperforming-sp-500-3585906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/UroGenPharma_priceRelatedfactors_3585906.png",
        "date": "2025-10-01 16:18:38",
        "description": "UroGen Pharma's stock surged significantly on September 30, 2025, reaching an intraday high and showcasing strong performance in the pharmaceuticals sector. Over the past year, the company has outperformed the S&P 500, but it faces challenges such as a negative book value and scrutiny over its debt servicing capabilities."
      }
    ],
    "total": 19,
    "sid": "1235717",
    "stock_news_url": "https://www.marketsmojo.com/news/urogen-pharma-1235717"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

UroGen Pharma Hits New 52-Week High of $23.89, Up 81.99%

2025-11-10 17:18:27

UroGen Pharma achieved a new 52-week high of USD 23.89 on November 7, 2025, marking an 81.99% increase over the past year. With a market capitalization of USD 991 million, the company has a notable return on equity of 165.96%, despite being currently loss-making.

UroGen Pharma Hits Day High with 18.83% Surge in Stock Price

2025-11-07 16:40:42

UroGen Pharma has seen notable stock activity, with significant gains over various time frames, including a 121.03% increase year-to-date. Despite challenges such as a negative book value and slow long-term growth, the company boasts a high return on equity of 165.96%.

UroGen Pharma Hits New 52-Week High of $23.64, Up 84.34%

2025-11-07 16:08:47

UroGen Pharma has achieved a new 52-week high of USD 23.64, significantly up from its low of USD 3.42, reflecting an impressive one-year performance. With a market cap of USD 991 million, the company shows strong financial metrics but remains loss-making, indicating evolving market dynamics in the Pharmaceuticals and Biotechnology sector.

Is UroGen Pharma Ltd. technically bullish or bearish?

2025-11-05 11:22:37

As of 31 October 2025, the technical trend for UroGen Pharma Ltd. has changed from mildly bullish to bullish. The current stance is bullish, supported by bullish signals from the daily moving averages and Bollinger Bands on both weekly and monthly time frames. However, the MACD shows a mildly bearish signal on the weekly, indicating some caution. In terms of performance, UroGen has significantly outperformed the S&P 500 year-to-date with a return of 86.01% compared to the S&P 500's 16.30%. Over the past year, the stock also shows strong performance at 62.38% against the S&P 500's 19.89%....

Is UroGen Pharma Ltd. technically bullish or bearish?

2025-11-04 11:34:07

As of 31 October 2025, the technical trend for UroGen Pharma Ltd. has changed from mildly bullish to bullish. The current stance is bullish, driven by bullish signals from the daily moving averages and Bollinger Bands on both weekly and monthly time frames. However, the MACD indicates a mildly bearish position on the weekly chart, while the monthly remains bullish. The KST shows a similar pattern with a mildly bearish weekly and bullish monthly. Dow Theory reflects a mildly bullish weekly stance but a mildly bearish monthly outlook. In terms of performance, UroGen Pharma has significantly outperformed the S&P 500 year-to-date with a return of 93.62% compared to the S&P's 16.30%, and over the past year, it has returned 69.02% against the S&P's 19.89%....

Is UroGen Pharma Ltd. technically bullish or bearish?

2025-11-03 11:33:54

As of 31 October 2025, the technical trend for UroGen Pharma Ltd. has changed from mildly bullish to bullish. The current stance is bullish, driven by bullish signals from the daily moving averages and Bollinger Bands on both weekly and monthly time frames. However, the MACD and KST indicators show a mildly bearish trend on the weekly, which suggests some caution. In terms of performance, UroGen has outperformed the S&P 500 significantly over the past week (7.91% vs. 0.71%) and month (14.90% vs. 1.92%), and has also shown strong year-to-date returns (92.21% vs. 16.30%). However, it has underperformed over the 3-year and 5-year periods compared to the S&P 500. Overall, the current bullish trend is supported by strong short-term performance, despite mixed signals from some indicators....

Is UroGen Pharma Ltd. technically bullish or bearish?

2025-11-02 11:18:26

As of 31 October 2025, the technical trend for UroGen Pharma Ltd. has changed from mildly bullish to bullish. The current stance is bullish overall, with key indicators supporting this view including bullish signals from the daily moving averages and both weekly and monthly Bollinger Bands. However, the weekly MACD and KST are mildly bearish, indicating some caution in the short term. The Dow Theory shows a mildly bullish stance on the weekly timeframe but is mildly bearish on the monthly. In terms of performance, UroGen Pharma has significantly outperformed the S&P 500 in the year-to-date return (92.21% vs. 16.30%) and over the past year (66.97% vs. 19.89%), though it has underperformed over the 3-year and 5-year periods....

UroGen Pharma Hits Day High with 9.46% Surge in Stock Price

2025-10-27 17:39:59

UroGen Pharma's stock has shown strong performance, gaining 9.46% on October 24, 2025, and achieving a 56.78% return over the past year. Despite challenges such as a negative book value and modest long-term growth, the company's market capitalization is currently USD 991 million.

UroGen Pharma Hits Day High with 15.59% Surge, Outperforming S&P 500

2025-10-01 16:18:38

UroGen Pharma's stock surged significantly on September 30, 2025, reaching an intraday high and showcasing strong performance in the pharmaceuticals sector. Over the past year, the company has outperformed the S&P 500, but it faces challenges such as a negative book value and scrutiny over its debt servicing capabilities.

View All News